Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Research Report 2026(Status and Outlook)
Neuromyelitis optica spectrum disorder (NMOSD), also known as Devic disease, is a chronic disorder of the brain and spinal cord dominated by inflammation of the optic nerve (optic neuritis) and the spinal cord (myelitis). Classically, it was felt to be a monophasic illness, consisting of episodes of inflammation of one or both optic nerves and the spinal cord over a short period of time (days or weeks) but, after the initial episode, no recurrence. It is now recognized that most patients satisfying current criteria for NMOSD experience repeated attacks separated by periods of remission. The interval between attacks may be weeks, months or years.
The global Neuromyelitis Optica Spectrum Disorder (Nmosd) market size was estimated at USD 259.5 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Neuromyelitis Optica Spectrum Disorder (Nmosd) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Neuromyelitis Optica Spectrum Disorder (Nmosd) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Neuromyelitis Optica Spectrum Disorder (Nmosd) market.
Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
F. Hoffmann-La Roche Ltd
Alexion Pharmaceuticals
RemeGen
Nihon Pharmaceutical
Harbour BioMed
Lundbeck
Bionure
Opexa Therapeutics
TG Therapeutics
Bio-Thera Solutions
Boston Pharmaceuticals
Cour Pharmaceutical
Market Segmentation (by Type)
Intravenous
Oral
Subcutaneous
Others
Market Segmentation (by Application)
Hospital
Clinic
Others
Geographic Segmentation
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Neuromyelitis Optica Spectrum Disorder (Nmosd) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Neuromyelitis Optica Spectrum Disorder (Nmosd), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Neuromyelitis Optica Spectrum Disorder (Nmosd) market size was estimated at USD 259.5 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Neuromyelitis Optica Spectrum Disorder (Nmosd) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Neuromyelitis Optica Spectrum Disorder (Nmosd) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Neuromyelitis Optica Spectrum Disorder (Nmosd) market.
Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
F. Hoffmann-La Roche Ltd
Alexion Pharmaceuticals
RemeGen
Nihon Pharmaceutical
Harbour BioMed
Lundbeck
Bionure
Opexa Therapeutics
TG Therapeutics
Bio-Thera Solutions
Boston Pharmaceuticals
Cour Pharmaceutical
Market Segmentation (by Type)
Intravenous
Oral
Subcutaneous
Others
Market Segmentation (by Application)
Hospital
Clinic
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Neuromyelitis Optica Spectrum Disorder (Nmosd) Market
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Neuromyelitis Optica Spectrum Disorder (Nmosd) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Neuromyelitis Optica Spectrum Disorder (Nmosd), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Neuromyelitis Optica Spectrum Disorder (Nmosd)
1.2 Key Market Segments
1.2.1 Neuromyelitis Optica Spectrum Disorder (Nmosd) Segment by Type
1.2.2 Neuromyelitis Optica Spectrum Disorder (Nmosd) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Life Cycle
3.3 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales by Manufacturers (2020-2025)
3.4 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Revenue Market Share by Manufacturers (2020-2025)
3.5 Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Competitive Situation and Trends
3.8.1 Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Concentration Rate
3.8.2 Global 5 and 10 Largest Neuromyelitis Optica Spectrum Disorder (Nmosd) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD) INDUSTRY CHAIN ANALYSIS
4.1 Neuromyelitis Optica Spectrum Disorder (Nmosd) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Neuromyelitis Optica Spectrum Disorder (Nmosd) Market
5.7 ESG Ratings of Leading Companies
6 NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Market Share by Type (2020-2025)
6.3 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Type (2020-2025)
6.4 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Price by Type (2020-2025)
7 NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Sales by Application (2020-2025)
7.3 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size (M USD) by Application (2020-2025)
7.4 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Growth Rate by Application (2020-2025)
8 NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD) MARKET SALES BY REGION
8.1 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales by Region
8.1.1 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales by Region
8.1.2 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Market Share by Region
8.2 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Region
8.2.1 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Region
8.2.2 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Region
8.3 North America
8.3.1 North America Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales by Country
8.3.2 North America Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales by Country
8.4.2 Europe Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales by Region
8.5.2 Asia Pacific Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales by Country
8.6.2 South America Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales by Region
8.7.2 Middle East and Africa Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD) MARKET PRODUCTION BY REGION
9.1 Global Production of Neuromyelitis Optica Spectrum Disorder (Nmosd) by Region(2020-2025)
9.2 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Revenue Market Share by Region (2020-2025)
9.3 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Neuromyelitis Optica Spectrum Disorder (Nmosd) Production
9.4.1 North America Neuromyelitis Optica Spectrum Disorder (Nmosd) Production Growth Rate (2020-2025)
9.4.2 North America Neuromyelitis Optica Spectrum Disorder (Nmosd) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Neuromyelitis Optica Spectrum Disorder (Nmosd) Production
9.5.1 Europe Neuromyelitis Optica Spectrum Disorder (Nmosd) Production Growth Rate (2020-2025)
9.5.2 Europe Neuromyelitis Optica Spectrum Disorder (Nmosd) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Neuromyelitis Optica Spectrum Disorder (Nmosd) Production (2020-2025)
9.6.1 Japan Neuromyelitis Optica Spectrum Disorder (Nmosd) Production Growth Rate (2020-2025)
9.6.2 Japan Neuromyelitis Optica Spectrum Disorder (Nmosd) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Neuromyelitis Optica Spectrum Disorder (Nmosd) Production (2020-2025)
9.7.1 China Neuromyelitis Optica Spectrum Disorder (Nmosd) Production Growth Rate (2020-2025)
9.7.2 China Neuromyelitis Optica Spectrum Disorder (Nmosd) Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 F. Hoffmann-La Roche Ltd
10.1.1 F. Hoffmann-La Roche Ltd Basic Information
10.1.2 F. Hoffmann-La Roche Ltd Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
10.1.3 F. Hoffmann-La Roche Ltd Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Market Performance
10.1.4 F. Hoffmann-La Roche Ltd Business Overview
10.1.5 F. Hoffmann-La Roche Ltd SWOT Analysis
10.1.6 F. Hoffmann-La Roche Ltd Recent Developments
10.2 Alexion Pharmaceuticals
10.2.1 Alexion Pharmaceuticals Basic Information
10.2.2 Alexion Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
10.2.3 Alexion Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Market Performance
10.2.4 Alexion Pharmaceuticals Business Overview
10.2.5 Alexion Pharmaceuticals SWOT Analysis
10.2.6 Alexion Pharmaceuticals Recent Developments
10.3 RemeGen
10.3.1 RemeGen Basic Information
10.3.2 RemeGen Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
10.3.3 RemeGen Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Market Performance
10.3.4 RemeGen Business Overview
10.3.5 RemeGen SWOT Analysis
10.3.6 RemeGen Recent Developments
10.4 Nihon Pharmaceutical
10.4.1 Nihon Pharmaceutical Basic Information
10.4.2 Nihon Pharmaceutical Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
10.4.3 Nihon Pharmaceutical Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Market Performance
10.4.4 Nihon Pharmaceutical Business Overview
10.4.5 Nihon Pharmaceutical Recent Developments
10.5 Harbour BioMed
10.5.1 Harbour BioMed Basic Information
10.5.2 Harbour BioMed Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
10.5.3 Harbour BioMed Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Market Performance
10.5.4 Harbour BioMed Business Overview
10.5.5 Harbour BioMed Recent Developments
10.6 Lundbeck
10.6.1 Lundbeck Basic Information
10.6.2 Lundbeck Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
10.6.3 Lundbeck Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Market Performance
10.6.4 Lundbeck Business Overview
10.6.5 Lundbeck Recent Developments
10.7 Bionure
10.7.1 Bionure Basic Information
10.7.2 Bionure Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
10.7.3 Bionure Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Market Performance
10.7.4 Bionure Business Overview
10.7.5 Bionure Recent Developments
10.8 Opexa Therapeutics
10.8.1 Opexa Therapeutics Basic Information
10.8.2 Opexa Therapeutics Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
10.8.3 Opexa Therapeutics Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Market Performance
10.8.4 Opexa Therapeutics Business Overview
10.8.5 Opexa Therapeutics Recent Developments
10.9 TG Therapeutics
10.9.1 TG Therapeutics Basic Information
10.9.2 TG Therapeutics Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
10.9.3 TG Therapeutics Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Market Performance
10.9.4 TG Therapeutics Business Overview
10.9.5 TG Therapeutics Recent Developments
10.10 Bio-Thera Solutions
10.10.1 Bio-Thera Solutions Basic Information
10.10.2 Bio-Thera Solutions Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
10.10.3 Bio-Thera Solutions Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Market Performance
10.10.4 Bio-Thera Solutions Business Overview
10.10.5 Bio-Thera Solutions Recent Developments
10.11 Boston Pharmaceuticals
10.11.1 Boston Pharmaceuticals Basic Information
10.11.2 Boston Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
10.11.3 Boston Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Market Performance
10.11.4 Boston Pharmaceuticals Business Overview
10.11.5 Boston Pharmaceuticals Recent Developments
10.12 Cour Pharmaceutical
10.12.1 Cour Pharmaceutical Basic Information
10.12.2 Cour Pharmaceutical Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
10.12.3 Cour Pharmaceutical Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Market Performance
10.12.4 Cour Pharmaceutical Business Overview
10.12.5 Cour Pharmaceutical Recent Developments
11 NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD) MARKET FORECAST BY REGION
11.1 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size Forecast
11.2 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size Forecast by Country
11.2.3 Asia Pacific Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size Forecast by Region
11.2.4 South America Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Neuromyelitis Optica Spectrum Disorder (Nmosd) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Neuromyelitis Optica Spectrum Disorder (Nmosd) by Type (2026-2035)
12.1.2 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Neuromyelitis Optica Spectrum Disorder (Nmosd) by Type (2026-2035)
12.2 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Forecast by Application (2026-2035)
12.2.1 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units) Forecast by Application
12.2.2 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Neuromyelitis Optica Spectrum Disorder (Nmosd)
1.2 Key Market Segments
1.2.1 Neuromyelitis Optica Spectrum Disorder (Nmosd) Segment by Type
1.2.2 Neuromyelitis Optica Spectrum Disorder (Nmosd) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Life Cycle
3.3 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales by Manufacturers (2020-2025)
3.4 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Revenue Market Share by Manufacturers (2020-2025)
3.5 Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Competitive Situation and Trends
3.8.1 Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Concentration Rate
3.8.2 Global 5 and 10 Largest Neuromyelitis Optica Spectrum Disorder (Nmosd) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD) INDUSTRY CHAIN ANALYSIS
4.1 Neuromyelitis Optica Spectrum Disorder (Nmosd) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Neuromyelitis Optica Spectrum Disorder (Nmosd) Market
5.7 ESG Ratings of Leading Companies
6 NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Market Share by Type (2020-2025)
6.3 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Type (2020-2025)
6.4 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Price by Type (2020-2025)
7 NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Sales by Application (2020-2025)
7.3 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size (M USD) by Application (2020-2025)
7.4 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Growth Rate by Application (2020-2025)
8 NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD) MARKET SALES BY REGION
8.1 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales by Region
8.1.1 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales by Region
8.1.2 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Market Share by Region
8.2 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Region
8.2.1 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Region
8.2.2 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Region
8.3 North America
8.3.1 North America Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales by Country
8.3.2 North America Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales by Country
8.4.2 Europe Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales by Region
8.5.2 Asia Pacific Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales by Country
8.6.2 South America Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales by Region
8.7.2 Middle East and Africa Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD) MARKET PRODUCTION BY REGION
9.1 Global Production of Neuromyelitis Optica Spectrum Disorder (Nmosd) by Region(2020-2025)
9.2 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Revenue Market Share by Region (2020-2025)
9.3 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Neuromyelitis Optica Spectrum Disorder (Nmosd) Production
9.4.1 North America Neuromyelitis Optica Spectrum Disorder (Nmosd) Production Growth Rate (2020-2025)
9.4.2 North America Neuromyelitis Optica Spectrum Disorder (Nmosd) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Neuromyelitis Optica Spectrum Disorder (Nmosd) Production
9.5.1 Europe Neuromyelitis Optica Spectrum Disorder (Nmosd) Production Growth Rate (2020-2025)
9.5.2 Europe Neuromyelitis Optica Spectrum Disorder (Nmosd) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Neuromyelitis Optica Spectrum Disorder (Nmosd) Production (2020-2025)
9.6.1 Japan Neuromyelitis Optica Spectrum Disorder (Nmosd) Production Growth Rate (2020-2025)
9.6.2 Japan Neuromyelitis Optica Spectrum Disorder (Nmosd) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Neuromyelitis Optica Spectrum Disorder (Nmosd) Production (2020-2025)
9.7.1 China Neuromyelitis Optica Spectrum Disorder (Nmosd) Production Growth Rate (2020-2025)
9.7.2 China Neuromyelitis Optica Spectrum Disorder (Nmosd) Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 F. Hoffmann-La Roche Ltd
10.1.1 F. Hoffmann-La Roche Ltd Basic Information
10.1.2 F. Hoffmann-La Roche Ltd Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
10.1.3 F. Hoffmann-La Roche Ltd Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Market Performance
10.1.4 F. Hoffmann-La Roche Ltd Business Overview
10.1.5 F. Hoffmann-La Roche Ltd SWOT Analysis
10.1.6 F. Hoffmann-La Roche Ltd Recent Developments
10.2 Alexion Pharmaceuticals
10.2.1 Alexion Pharmaceuticals Basic Information
10.2.2 Alexion Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
10.2.3 Alexion Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Market Performance
10.2.4 Alexion Pharmaceuticals Business Overview
10.2.5 Alexion Pharmaceuticals SWOT Analysis
10.2.6 Alexion Pharmaceuticals Recent Developments
10.3 RemeGen
10.3.1 RemeGen Basic Information
10.3.2 RemeGen Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
10.3.3 RemeGen Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Market Performance
10.3.4 RemeGen Business Overview
10.3.5 RemeGen SWOT Analysis
10.3.6 RemeGen Recent Developments
10.4 Nihon Pharmaceutical
10.4.1 Nihon Pharmaceutical Basic Information
10.4.2 Nihon Pharmaceutical Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
10.4.3 Nihon Pharmaceutical Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Market Performance
10.4.4 Nihon Pharmaceutical Business Overview
10.4.5 Nihon Pharmaceutical Recent Developments
10.5 Harbour BioMed
10.5.1 Harbour BioMed Basic Information
10.5.2 Harbour BioMed Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
10.5.3 Harbour BioMed Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Market Performance
10.5.4 Harbour BioMed Business Overview
10.5.5 Harbour BioMed Recent Developments
10.6 Lundbeck
10.6.1 Lundbeck Basic Information
10.6.2 Lundbeck Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
10.6.3 Lundbeck Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Market Performance
10.6.4 Lundbeck Business Overview
10.6.5 Lundbeck Recent Developments
10.7 Bionure
10.7.1 Bionure Basic Information
10.7.2 Bionure Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
10.7.3 Bionure Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Market Performance
10.7.4 Bionure Business Overview
10.7.5 Bionure Recent Developments
10.8 Opexa Therapeutics
10.8.1 Opexa Therapeutics Basic Information
10.8.2 Opexa Therapeutics Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
10.8.3 Opexa Therapeutics Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Market Performance
10.8.4 Opexa Therapeutics Business Overview
10.8.5 Opexa Therapeutics Recent Developments
10.9 TG Therapeutics
10.9.1 TG Therapeutics Basic Information
10.9.2 TG Therapeutics Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
10.9.3 TG Therapeutics Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Market Performance
10.9.4 TG Therapeutics Business Overview
10.9.5 TG Therapeutics Recent Developments
10.10 Bio-Thera Solutions
10.10.1 Bio-Thera Solutions Basic Information
10.10.2 Bio-Thera Solutions Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
10.10.3 Bio-Thera Solutions Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Market Performance
10.10.4 Bio-Thera Solutions Business Overview
10.10.5 Bio-Thera Solutions Recent Developments
10.11 Boston Pharmaceuticals
10.11.1 Boston Pharmaceuticals Basic Information
10.11.2 Boston Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
10.11.3 Boston Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Market Performance
10.11.4 Boston Pharmaceuticals Business Overview
10.11.5 Boston Pharmaceuticals Recent Developments
10.12 Cour Pharmaceutical
10.12.1 Cour Pharmaceutical Basic Information
10.12.2 Cour Pharmaceutical Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
10.12.3 Cour Pharmaceutical Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Market Performance
10.12.4 Cour Pharmaceutical Business Overview
10.12.5 Cour Pharmaceutical Recent Developments
11 NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD) MARKET FORECAST BY REGION
11.1 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size Forecast
11.2 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size Forecast by Country
11.2.3 Asia Pacific Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size Forecast by Region
11.2.4 South America Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Neuromyelitis Optica Spectrum Disorder (Nmosd) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Neuromyelitis Optica Spectrum Disorder (Nmosd) by Type (2026-2035)
12.1.2 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Neuromyelitis Optica Spectrum Disorder (Nmosd) by Type (2026-2035)
12.2 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Forecast by Application (2026-2035)
12.2.1 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units) Forecast by Application
12.2.2 Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Type (M USD)
Table 4. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Application
Table 5. Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size Comparison by Region (M USD)
Table 6. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuromyelitis Optica Spectrum Disorder (Nmosd) as of 2025)
Table 11. Global Market Neuromyelitis Optica Spectrum Disorder (Nmosd) Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales by Type (K Units)
Table 27. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Type (M USD)
Table 28. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units) by Type (2020-2025)
Table 29. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Market Share by Type (2020-2025)
Table 30. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size (M USD) by Type (2020-2025)
Table 31. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Share by Type (2020-2025)
Table 32. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Price (USD/Unit) by Type (2020-2025)
Table 33. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units) by Application
Table 34. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Application
Table 35. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales by Application (2020-2025) & (K Units)
Table 36. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Market Share by Application (2020-2025)
Table 37. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Application (2020-2025) & (M USD)
Table 38. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Share by Application (2020-2025)
Table 39. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Growth Rate by Application (2020-2025)
Table 40. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales by Region (2020-2025) & (K Units)
Table 41. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Market Share by Region (2020-2025)
Table 42. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Region (2020-2025) & (M USD)
Table 43. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Region (2020-2025)
Table 44. North America Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales by Country (2020-2025) & (K Units)
Table 45. North America Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales by Country (2020-2025) & (K Units)
Table 47. Europe Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Region (2020-2025) & (M USD)
Table 50. South America Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales by Country (2020-2025) & (K Units)
Table 51. South America Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Region (2020-2025) & (M USD)
Table 54. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Production (K Units) by Region(2020-2025)
Table 55. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Revenue Market Share by Region (2020-2025)
Table 57. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Neuromyelitis Optica Spectrum Disorder (Nmosd) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Neuromyelitis Optica Spectrum Disorder (Nmosd) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Neuromyelitis Optica Spectrum Disorder (Nmosd) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Neuromyelitis Optica Spectrum Disorder (Nmosd) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. F. Hoffmann-La Roche Ltd Basic Information
Table 63. F. Hoffmann-La Roche Ltd Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
Table 64. F. Hoffmann-La Roche Ltd Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. F. Hoffmann-La Roche Ltd Business Overview
Table 66. F. Hoffmann-La Roche Ltd SWOT Analysis
Table 67. F. Hoffmann-La Roche Ltd Recent Developments
Table 68. Alexion Pharmaceuticals Basic Information
Table 69. Alexion Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
Table 70. Alexion Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Alexion Pharmaceuticals Business Overview
Table 72. Alexion Pharmaceuticals SWOT Analysis
Table 73. Alexion Pharmaceuticals Recent Developments
Table 74. RemeGen Basic Information
Table 75. RemeGen Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
Table 76. RemeGen Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. RemeGen Business Overview
Table 78. RemeGen SWOT Analysis
Table 79. RemeGen Recent Developments
Table 80. Nihon Pharmaceutical Basic Information
Table 81. Nihon Pharmaceutical Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
Table 82. Nihon Pharmaceutical Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Nihon Pharmaceutical Business Overview
Table 84. Nihon Pharmaceutical Recent Developments
Table 85. Harbour BioMed Basic Information
Table 86. Harbour BioMed Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
Table 87. Harbour BioMed Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Harbour BioMed Business Overview
Table 89. Harbour BioMed Recent Developments
Table 90. Lundbeck Basic Information
Table 91. Lundbeck Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
Table 92. Lundbeck Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Lundbeck Business Overview
Table 94. Lundbeck Recent Developments
Table 95. Bionure Basic Information
Table 96. Bionure Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
Table 97. Bionure Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Bionure Business Overview
Table 99. Bionure Recent Developments
Table 100. Opexa Therapeutics Basic Information
Table 101. Opexa Therapeutics Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
Table 102. Opexa Therapeutics Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Opexa Therapeutics Business Overview
Table 104. Opexa Therapeutics Recent Developments
Table 105. TG Therapeutics Basic Information
Table 106. TG Therapeutics Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
Table 107. TG Therapeutics Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. TG Therapeutics Business Overview
Table 109. TG Therapeutics Recent Developments
Table 110. Bio-Thera Solutions Basic Information
Table 111. Bio-Thera Solutions Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
Table 112. Bio-Thera Solutions Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Bio-Thera Solutions Business Overview
Table 114. Bio-Thera Solutions Recent Developments
Table 115. Boston Pharmaceuticals Basic Information
Table 116. Boston Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
Table 117. Boston Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Boston Pharmaceuticals Business Overview
Table 119. Boston Pharmaceuticals Recent Developments
Table 120. Cour Pharmaceutical Basic Information
Table 121. Cour Pharmaceutical Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
Table 122. Cour Pharmaceutical Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Cour Pharmaceutical Business Overview
Table 124. Cour Pharmaceutical Recent Developments
Table 125. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Forecast by Region (2026-2035) & (K Units)
Table 126. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size Forecast by Region (2026-2035) & (M USD)
Table 127. North America Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Forecast by Country (2026-2035) & (K Units)
Table 128. North America Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size Forecast by Country (2026-2035) & (M USD)
Table 129. Europe Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Forecast by Country (2026-2035) & (K Units)
Table 130. Europe Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size Forecast by Country (2026-2035) & (M USD)
Table 131. Asia Pacific Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Forecast by Region (2026-2035) & (K Units)
Table 132. Asia Pacific Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size Forecast by Region (2026-2035) & (M USD)
Table 133. South America Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Forecast by Country (2026-2035) & (K Units)
Table 134. South America Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size Forecast by Country (2026-2035) & (M USD)
Table 135. Middle East and Africa Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Forecast by Country (2026-2035) & (Units)
Table 136. Middle East and Africa Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size Forecast by Country (2026-2035) & (M USD)
Table 137. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Forecast by Type (2026-2035) & (K Units)
Table 138. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size Forecast by Type (2026-2035) & (M USD)
Table 139. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Price Forecast by Type (2026-2035) & (USD/Unit)
Table 140. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units) Forecast by Application (2026-2035)
Table 141. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Type (M USD)
Table 4. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Application
Table 5. Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size Comparison by Region (M USD)
Table 6. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuromyelitis Optica Spectrum Disorder (Nmosd) as of 2025)
Table 11. Global Market Neuromyelitis Optica Spectrum Disorder (Nmosd) Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales by Type (K Units)
Table 27. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Type (M USD)
Table 28. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units) by Type (2020-2025)
Table 29. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Market Share by Type (2020-2025)
Table 30. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size (M USD) by Type (2020-2025)
Table 31. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Share by Type (2020-2025)
Table 32. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Price (USD/Unit) by Type (2020-2025)
Table 33. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units) by Application
Table 34. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Application
Table 35. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales by Application (2020-2025) & (K Units)
Table 36. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Market Share by Application (2020-2025)
Table 37. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Application (2020-2025) & (M USD)
Table 38. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Share by Application (2020-2025)
Table 39. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Growth Rate by Application (2020-2025)
Table 40. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales by Region (2020-2025) & (K Units)
Table 41. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Market Share by Region (2020-2025)
Table 42. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Region (2020-2025) & (M USD)
Table 43. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Region (2020-2025)
Table 44. North America Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales by Country (2020-2025) & (K Units)
Table 45. North America Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales by Country (2020-2025) & (K Units)
Table 47. Europe Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Region (2020-2025) & (M USD)
Table 50. South America Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales by Country (2020-2025) & (K Units)
Table 51. South America Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Region (2020-2025) & (M USD)
Table 54. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Production (K Units) by Region(2020-2025)
Table 55. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Revenue Market Share by Region (2020-2025)
Table 57. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Neuromyelitis Optica Spectrum Disorder (Nmosd) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Neuromyelitis Optica Spectrum Disorder (Nmosd) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Neuromyelitis Optica Spectrum Disorder (Nmosd) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Neuromyelitis Optica Spectrum Disorder (Nmosd) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. F. Hoffmann-La Roche Ltd Basic Information
Table 63. F. Hoffmann-La Roche Ltd Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
Table 64. F. Hoffmann-La Roche Ltd Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. F. Hoffmann-La Roche Ltd Business Overview
Table 66. F. Hoffmann-La Roche Ltd SWOT Analysis
Table 67. F. Hoffmann-La Roche Ltd Recent Developments
Table 68. Alexion Pharmaceuticals Basic Information
Table 69. Alexion Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
Table 70. Alexion Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Alexion Pharmaceuticals Business Overview
Table 72. Alexion Pharmaceuticals SWOT Analysis
Table 73. Alexion Pharmaceuticals Recent Developments
Table 74. RemeGen Basic Information
Table 75. RemeGen Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
Table 76. RemeGen Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. RemeGen Business Overview
Table 78. RemeGen SWOT Analysis
Table 79. RemeGen Recent Developments
Table 80. Nihon Pharmaceutical Basic Information
Table 81. Nihon Pharmaceutical Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
Table 82. Nihon Pharmaceutical Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Nihon Pharmaceutical Business Overview
Table 84. Nihon Pharmaceutical Recent Developments
Table 85. Harbour BioMed Basic Information
Table 86. Harbour BioMed Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
Table 87. Harbour BioMed Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Harbour BioMed Business Overview
Table 89. Harbour BioMed Recent Developments
Table 90. Lundbeck Basic Information
Table 91. Lundbeck Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
Table 92. Lundbeck Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Lundbeck Business Overview
Table 94. Lundbeck Recent Developments
Table 95. Bionure Basic Information
Table 96. Bionure Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
Table 97. Bionure Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Bionure Business Overview
Table 99. Bionure Recent Developments
Table 100. Opexa Therapeutics Basic Information
Table 101. Opexa Therapeutics Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
Table 102. Opexa Therapeutics Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Opexa Therapeutics Business Overview
Table 104. Opexa Therapeutics Recent Developments
Table 105. TG Therapeutics Basic Information
Table 106. TG Therapeutics Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
Table 107. TG Therapeutics Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. TG Therapeutics Business Overview
Table 109. TG Therapeutics Recent Developments
Table 110. Bio-Thera Solutions Basic Information
Table 111. Bio-Thera Solutions Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
Table 112. Bio-Thera Solutions Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Bio-Thera Solutions Business Overview
Table 114. Bio-Thera Solutions Recent Developments
Table 115. Boston Pharmaceuticals Basic Information
Table 116. Boston Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
Table 117. Boston Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Boston Pharmaceuticals Business Overview
Table 119. Boston Pharmaceuticals Recent Developments
Table 120. Cour Pharmaceutical Basic Information
Table 121. Cour Pharmaceutical Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Overview
Table 122. Cour Pharmaceutical Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Cour Pharmaceutical Business Overview
Table 124. Cour Pharmaceutical Recent Developments
Table 125. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Forecast by Region (2026-2035) & (K Units)
Table 126. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size Forecast by Region (2026-2035) & (M USD)
Table 127. North America Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Forecast by Country (2026-2035) & (K Units)
Table 128. North America Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size Forecast by Country (2026-2035) & (M USD)
Table 129. Europe Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Forecast by Country (2026-2035) & (K Units)
Table 130. Europe Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size Forecast by Country (2026-2035) & (M USD)
Table 131. Asia Pacific Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Forecast by Region (2026-2035) & (K Units)
Table 132. Asia Pacific Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size Forecast by Region (2026-2035) & (M USD)
Table 133. South America Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Forecast by Country (2026-2035) & (K Units)
Table 134. South America Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size Forecast by Country (2026-2035) & (M USD)
Table 135. Middle East and Africa Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Forecast by Country (2026-2035) & (Units)
Table 136. Middle East and Africa Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size Forecast by Country (2026-2035) & (M USD)
Table 137. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Forecast by Type (2026-2035) & (K Units)
Table 138. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size Forecast by Type (2026-2035) & (M USD)
Table 139. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Price Forecast by Type (2026-2035) & (USD/Unit)
Table 140. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units) Forecast by Application (2026-2035)
Table 141. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Neuromyelitis Optica Spectrum Disorder (Nmosd)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size (M USD), 2025-2035
Figure 5. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size (M USD) (2020-2035)
Figure 6. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Life Cycle
Figure 13. Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Share by Manufacturers in 2025
Figure 14. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Revenue Share by Manufacturers in 2025
Figure 15. Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Neuromyelitis Optica Spectrum Disorder (Nmosd) Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Neuromyelitis Optica Spectrum Disorder (Nmosd) Revenue in 2025
Figure 18. Industry Chain Map of Neuromyelitis Optica Spectrum Disorder (Nmosd)
Figure 19. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market PEST Analysis
Figure 20. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Share by Type
Figure 27. Sales Market Share of Neuromyelitis Optica Spectrum Disorder (Nmosd) by Type (2020-2025)
Figure 28. Sales Market Share of Neuromyelitis Optica Spectrum Disorder (Nmosd) by Type in 2025
Figure 29. Market Share of Neuromyelitis Optica Spectrum Disorder (Nmosd) by Type (2020-2025)
Figure 30. Market Share of Neuromyelitis Optica Spectrum Disorder (Nmosd) by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Share by Application
Figure 33. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Market Share by Application (2020-2025)
Figure 34. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Market Share by Application in 2025
Figure 35. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Share by Application (2020-2025)
Figure 36. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Share by Application in 2025
Figure 37. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Growth Rate by Application (2020-2025)
Figure 38. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Market Share by Region (2020-2025)
Figure 39. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Region (2020-2025)
Figure 40. North America Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Market Share by Country in 2024
Figure 43. North America Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Country in 2024
Figure 45. U.S. Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Market Share by Country in 2024
Figure 53. Europe Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Country in 2024
Figure 55. Germany Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Market Share by Region in 2024
Figure 67. Asia Pacific Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Region in 2024
Figure 68. China Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (K Units)
Figure 79. South America Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Market Share by Country in 2024
Figure 80. South America Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (M USD)
Figure 81. South America Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Country in 2024
Figure 82. Brazil Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Region in 2024
Figure 92. Saudi Arabia Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Production Market Share by Region (2020-2025)
Figure 103. North America Neuromyelitis Optica Spectrum Disorder (Nmosd) Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Neuromyelitis Optica Spectrum Disorder (Nmosd) Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Neuromyelitis Optica Spectrum Disorder (Nmosd) Production (K Units) Growth Rate (2020-2025)
Figure 106. China Neuromyelitis Optica Spectrum Disorder (Nmosd) Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Share Forecast by Type (2026-2035)
Figure 111. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Forecast by Application (2026-2035)
Figure 112. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Neuromyelitis Optica Spectrum Disorder (Nmosd)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size (M USD), 2025-2035
Figure 5. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size (M USD) (2020-2035)
Figure 6. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Product Life Cycle
Figure 13. Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Share by Manufacturers in 2025
Figure 14. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Revenue Share by Manufacturers in 2025
Figure 15. Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Neuromyelitis Optica Spectrum Disorder (Nmosd) Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Neuromyelitis Optica Spectrum Disorder (Nmosd) Revenue in 2025
Figure 18. Industry Chain Map of Neuromyelitis Optica Spectrum Disorder (Nmosd)
Figure 19. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market PEST Analysis
Figure 20. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Share by Type
Figure 27. Sales Market Share of Neuromyelitis Optica Spectrum Disorder (Nmosd) by Type (2020-2025)
Figure 28. Sales Market Share of Neuromyelitis Optica Spectrum Disorder (Nmosd) by Type in 2025
Figure 29. Market Share of Neuromyelitis Optica Spectrum Disorder (Nmosd) by Type (2020-2025)
Figure 30. Market Share of Neuromyelitis Optica Spectrum Disorder (Nmosd) by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Share by Application
Figure 33. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Market Share by Application (2020-2025)
Figure 34. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Market Share by Application in 2025
Figure 35. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Share by Application (2020-2025)
Figure 36. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Share by Application in 2025
Figure 37. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Growth Rate by Application (2020-2025)
Figure 38. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Market Share by Region (2020-2025)
Figure 39. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Region (2020-2025)
Figure 40. North America Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Market Share by Country in 2024
Figure 43. North America Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Country in 2024
Figure 45. U.S. Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Market Share by Country in 2024
Figure 53. Europe Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Country in 2024
Figure 55. Germany Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Market Share by Region in 2024
Figure 67. Asia Pacific Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Region in 2024
Figure 68. China Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (K Units)
Figure 79. South America Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Market Share by Country in 2024
Figure 80. South America Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (M USD)
Figure 81. South America Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Country in 2024
Figure 82. Brazil Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size by Region in 2024
Figure 92. Saudi Arabia Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Production Market Share by Region (2020-2025)
Figure 103. North America Neuromyelitis Optica Spectrum Disorder (Nmosd) Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Neuromyelitis Optica Spectrum Disorder (Nmosd) Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Neuromyelitis Optica Spectrum Disorder (Nmosd) Production (K Units) Growth Rate (2020-2025)
Figure 106. China Neuromyelitis Optica Spectrum Disorder (Nmosd) Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Share Forecast by Type (2026-2035)
Figure 111. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Sales Forecast by Application (2026-2035)
Figure 112. Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market Share Forecast by Application (2026-2035)
